BAMCO Inc’s Myovant Sciences Ltd. MYOV Stock Holding History

BAMCO Inc’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-168,000	Closed	-$1.52M	–	372
2019 Q2	$1.52M	Hold	168,000	–	–	0.01%	299
2019 Q1	$4.01M	Buy	168,000 +28,000	+20%	+$573K	0.02%	266
2018 Q4	$2.3M	Buy	140,000 +7,239	+5%	+$143K	0.01%	281
2018 Q3	$3.52M	Buy	132,761 +74,561	+128%	+$1.69M	0.01%	273
2018 Q2	$1.33M	Buy	+58,200	New	+$1.27M	0.01%	291

Other funds holding MYOV

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

NCM

NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BAMCO Inc's MYOV Position: Q3 2019 in Review

BAMCO Inc sold out of Myovant Sciences Ltd. (MYOV) in Q3 2019, closing a stake of 168,000 shares — an estimated $1.52M sold.

BAMCO Inc first reported a position in MYOV in Q2 2018 and held it in 5 quarters. The position peaked at $4.01M in Q1 2019. 65 funds tracked by Wall St. Rank hold MYOV as of Q3 2019.

BAMCO Inc reported no remaining Myovant Sciences Ltd. position as of Q3 2019 after selling out during the quarter.
BAMCO Inc sold 168,000 Myovant Sciences Ltd. shares in Q3 2019, an estimated $1.52M.
BAMCO Inc first reported a position in Myovant Sciences Ltd. in Q2 2018 and held it in 5 quarters.
BAMCO Inc's Myovant Sciences Ltd. position peaked at $4.01M in Q1 2019.
65 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2019.

Based on BAMCO Inc's 13F filing for Q3 2019, filed 14 Nov 2019.